Acadian Asset Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,012
| Closed | -$120K | – | 1779 |
|
|
2024
Q1 | $120K | Sell |
4,012
-13,876
| -78% | -$415K | ﹤0.01% | 1259 |
|
|
2023
Q4 | $184K | Sell |
17,888
-4,411
| -20% | -$45.4K | ﹤0.01% | 1248 |
|
|
2023
Q3 | $303K | Sell |
22,299
-6,307
| -22% | -$85.7K | ﹤0.01% | 1115 |
|
|
2023
Q2 | $346K | Sell |
28,606
-9,782
| -25% | -$118K | ﹤0.01% | 1144 |
|
|
2023
Q1 | $486K | Buy |
38,388
+30,838
| +408% | +$390K | ﹤0.01% | 1057 |
|
|
2022
Q4 | $46K | Buy |
7,550
+1,610
| +27% | +$9.81K | ﹤0.01% | 1585 |
|
|
2022
Q3 | $132K | Buy |
5,940
+1,319
| +29% | +$29.3K | ﹤0.01% | 1295 |
|
|
2022
Q2 | $89K | Buy |
4,621
+3,416
| +283% | +$65.8K | ﹤0.01% | 1382 |
|
|
2022
Q1 | $55K | Buy |
1,205
+790
| +190% | +$36.1K | ﹤0.01% | 1454 |
|
|
2021
Q4 | $29K | Buy |
+415
| New | +$29K | ﹤0.01% | 1564 |
|